Utah Medical Products Inc (UTMD) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Utah Medical Products Inc  (NASDAQ: UTMD)

Utah Medical Products Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Utah Medical Products Inc in the second quarter 2026?
Utah Medical Products Inc achieved a return on average equity (ROE) of 8.74 % in its second quarter 2026, which is below Utah Medical Products Inc's average return on equity, which stands at 15.46%.

ROE fell compared to the first quarter 2026, despite the net income growth of 3.15% from the first quarter 2026.

Within the Medical Equipment & Supplies industry 45 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 1554, from total ROE ranking in the first quarter 2026 at 1693.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Equity Change 3.83 % 2.84 % 1.57 % -4.79 % -
Y / Y Net Income Change -11.88 % -14.37 % -11.61 % -26.16 % -11.73 %
Net Income (TTM) in Millions 10 11 11 12 13
Return On Equity (TTM) 8.74 % 9.13 % 9.56 % 9.89 % 10.55 %
UTMD's Total Ranking # 1554 # 1693 # 1391 # 1307 # 1266
Equity (TTM) in Millions 122 120 119 118 118
Seq. Equity Change 1.38 % 0.93 % 0.86 % 0.61 % 0.42 %
Seq. Net Income Change 3.15 % 1.52 % -2.51 % -13.68 % 0.23 %

Back to UTMD Management Effectiveness >> UTMD's 5 Years Annual ROE >> Compare UTMD ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 46
Sector # 153
Overall # 1554

Return On Equity Statistics
High Average Low
22.13 %
15.46 %
8.74 %
(Sep 30 2012)   (Jun 30 2026)





UTMD Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 119 117 128 114 107
Y / Y Equity Change 1.57 % -8.48 % 12.31 % 6.64 % 4.2 %
Net Income in Millions 11 14 17 16 15
Y / Y Net Income Change -18.65 % -16.6 % 0.98 % 11.39 % 36.95 %
Return On Equity 9.46 % 11.81 % 12.96 % 14.42 % 13.8 %

Back to UTMD Management Effectiveness >> UTMD's 5 Years Annual ROE >> Compare UTMD ROE to its Competitors




Annual Roe Comment
In 2025 ROE decreased compared to the previous year to 9.46 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
UTMD's' Return on Equity at Yahoo Finance
UTMD's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for UTMD's Competitors
Subscribers only: Roe for Utah Medical Products Inc's Suppliers
Subscribers only: Return On Equity for UTMD's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Electromed Inc   23.65 %
Iradimed Corporation  23.45 %
Vertex Pharmaceuticals Inc  23.31 %
Lantheus Holdings Inc   23.27 %
Msa Safety Inc  23.15 %
Prestige Consumer Healthcare Inc   21.77 %
Jazz Pharmaceuticals Plc  21.37 %
Neurocrine Biosciences Inc   21.13 %
Universal Health Services Inc   20.89 %
Puma Biotechnology Inc   20.85 %
Entera Bio Ltd   20.82 %
United Therapeutics Corporation  20.18 %
Ligand Pharmaceuticals Incorporated  20.06 %
Harmony Biosciences Holdings inc   20.06 %
Pediatrix Medical Group Inc   19.89 %
Theravance Biopharma inc   19.40 %
Krystal Biotech Inc   19.34 %
Ani Pharmaceuticals Inc  19.33 %
Brightspring Health Services Inc   18.93 %
Sbc Medical Group Holdings Incorporated  18.69 %
West Pharmaceutical Services Inc   18.51 %
Intuitive Surgical Inc   17.82 %
Standard Biotools Inc   17.64 %
Inspire Medical Systems inc   17.62 %
Medinotec Inc   17.47 %
Lemaitre Vascular Inc   16.93 %
Ufp Technologies Inc   16.72 %
Ensign Group Inc  16.53 %
Stryker Corp  16.36 %
Nephros Inc   16.20 %

Date modified: 2026-09-04T10:52:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.